Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05788666

Enrollment

150

Registered

2023-03-29

Start date

2024-01-18

Completion date

2027-12-31

Last updated

2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease

Keywords

GeriKit, Comprehensive Geriatric Assessment (CGA)

Brief summary

This study seeks to expand the use of the NYU GeriKit mobile application (app) in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.

Detailed description

This is a single-center proof of concept study of geriatric impairments and feasibility metrics through the use of the GeriKit software application in older adults with ischemic heart disease at the NYU Langone Medical Center. The GeriKit mobile application was developed to make geriatric assessment instruments easily accessible to clinicians who do not have subspecialty training in geriatrics. The GeriKit app has been used clinically but is untested in research settings.

Interventions

PROCEDUREGeriKit Mobile Application

Digital health app used for comprehensive geriatric assessment (CGA). The app includes a series of brief, well-validated instruments: the MiniCog, 30-Second Chair Stand, Activities of Daily Living, Instrumental Activities of Daily Living, Patient Health Questionnaire (PHQ-9), Mini Nutrition Assessment, 2-Item Fall Screen, and Polypharmacy screen.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

75 Years to 100 Years

Healthy volunteers

Inclusion criteria

1. Age ≥ 75 2. Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or hospitalized for AMI, PCI, or CABG within the prior 4 weeks 3. Capable of self-consent 4. Understand and are able to perform study procedures in English

Exclusion criteria

1. Non-ambulatory 2. Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia) 3. Unable or unwilling to consent 4. Incarcerated 5. Unable to use complete assessments in English 6. Unable to complete geriatric assessment for other reasons

Design outcomes

Primary

Measure	Time frame	Description
Incidence of Mortality or Hospital Readmission	Month 6	Binary outcome; determined by review of patient electronic health record (EHR) data at Month 6.

Secondary

Measure	Time frame	Description
12-Item Short Form Survey (SF-12) Score	Baseline	The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality-of-life measure. SF-12 consists of 12 questions that are scored in various ways. The total score range is 12-48; the higher the score, the higher the score, the better the physical and mental health functioning.
Seattle Angina Questionnaire Short-Form (SAQ-7)	Baseline	7-item questionnaire assessing functional status, angina and disease-specific health-related quality of life (HRQoL) over a four-week recall period. Responses generate a summary score ranging from 0-100, where 100 = full health, and 0 = worst health.

Countries

United States

Contacts

Primary ContactJohn A. Dodson, MD, MPH, FACC

Cdhlab@nyulangone.org(646) 501-2714

Backup ContactVictoria Rosado Santiago

victoria.rosadosantiago@nyulangone.org9(917) 838-1699

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026